MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.compbiolchem.2026.109156

Медицинская библиотека · Computational biology and chemistry · 2026

AI-driven transformer-guided fragment-based discovery of Prostaglandin A1 as a multi-target inhibitor of PSAT1, PARP1, and PIK3CA in ovarian cancer.

Sun Yaping, Gangwar Shalesh, Qu Jinfeng, Raza Khalid

СтатьяПеревод пока не подготовлен

Аннотация

Ovarian cancer remains a major clinical challenge because of pathway redundancy and therapeutic resistance, which limit the effectiveness of drugs targeting a single target. Multi-target inhibitors can simultaneously modulate key oncogenic proteins such as PSAT1, PARP1, and PIK3CA. However, identifying multi-targeted compounds remains difficult due to limitations in conventional screening approaches and chemical library diversity. In this study, we developed an integrated computational framework that combines fragment-based drug design and transformer-driven molecular screening to discover multi-target inhibitors against Ovarian Cancer. Fragment screening and optimization were performed to identify scaffold features that are compatible with all three proteins (PSAT1, PARP1, and PIK3CA). Then, in order to expand the search beyond traditional libraries, a ChemBERTa transformer model was used to perform similarity-based screening of the TCM Bank dataset, which enables prioritization of compounds aligned with fragment-derived pharmacophore characteristics. This approach identified Prostaglandin A1 as a promising multitarget candidate, demonstrating favorable predicted binding interactions with three key oncogenic proteins. Also, Prostaglandin A1 exhibited favorable WaterMap ΔG values and hydration thermodynamic profiles. The binding stability was further validated through molecular dynamics simulations followed by MM/GBSA analysis. Notably, the presence of Prostaglandin A1 in medicinal plants such as Cnidium monnieri and Allium macrostemon further supports its translational potential.

Для цитирования: Sun Yaping, Gangwar Shalesh, Qu Jinfeng, Raza Khalid. AI-driven transformer-guided fragment-based discovery of Prostaglandin A1 as a multi-target inhibitor of PSAT1, PARP1, and PIK3CA in ovarian cancer.. Computational biology and chemistry. 2026. DOI: 10.1016/j.compbiolchem.2026.109156.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.